An experimental leukemia drug from Ariad Pharmaceuticals Inc eliminated the cancer from the bone marrow of nearly half of patients with a chronic form of the disease who had stopped responding to other drugs, according to a 12-month follow-up of a pivotal drug trial. Continue reading….
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply